JPRN-UMIN000018192
Completed
未知
A prospective, multi-center, single-arm study of tOCP/Col for guided bone regeneration - A prospective, multi-center, single-arm study of OCP/Col
Conditionsbone defect
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- bone defect
- Sponsor
- TOYOBO CO., LTD.
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patient suffering severe hepatopathy, renal disorders, and heart disease who would affect safety evaluation of this trial. Patient who has an allergy drug. Patient who has a bone metabolism disease like osteoporosis or has a medication of bisphosphonate. Patient who has a medication of steroid or immunosuppressant (The local administration is excluded). Patient who receives an anticoagulant therapy. Patient who is pregnant, possibly pregnant, nursing or considering pregnancy. Patient who has an uncontroled diabetes. Smoker, but the patient who was able to confirm intention of the smoking cessation before clinical trial participation is excluded. Patient who participated other clinical trial program within 3 months prior to the study entry Others, patient who is unfit for the study as determined by the principal investigator or sub\-investigators
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
The DeLIVER NZ Study will evaluate the safety of the Integrated Radio Frequency (iRF) Denervation System which is designed to improve blood pressure in patients with hypertnesion.Type 2 Diabetes MellitusHypertensionMetabolic and Endocrine - DiabetesCardiovascular - HypertensionMetabolic and Endocrine - Other metabolic disordersMetabolic and Endocrine - Metabolic disordersACTRN12619001524189Metavention, Inc.30
Not yet recruiting
Not Applicable
A multi-center, single arm, prospective study of the WallFlex biliary partially covered stent for the palliative treatment of malignant bile duct obstruction.Malignant biliary obstructionmalignant obstruction of the biliary tract10019815NL-OMON30737Boston Scientific Corporation18
Recruiting
Not Applicable
SPECTACLE studyRectal cancerJPRN-jRCTs032230212Watanabe Jun400
Completed
Not Applicable
A multicenter, open-label, single-arm study of a TRPV2 inhibitor against cardiomyopathy of muscular dystrophyJPRN-UMIN000031965ational Hospital Organization Toneyama National Hospital20
Active, not recruiting
Not Applicable
Tranilast-MDmuscular dystrophymuscular dystrophy ,heart failure ,tranilastmuscular dystrophiesJPRN-jRCTs031180038Matsumura Tsuyoshi20